The systemic inflammatory response syndrome

Total Burn Care

Volumn , Issue , 2007, Pages 292-309

  Sherwood, Edward R ^a   Traber, Daniel L ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 64049109494     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-3274-8.50025-8     Document Type: Chapter

References (181)

1. RC Bone, RA Balk, FB Cerra, et al. (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101 1644-1655.
2. DJ Muckart and S Bhagwanjee (1997) American College of Chest Physicians/Society of Crit Care Med Consensus Conference definitions of the systemic inflammatory response syndrome and allied disorders in relation to critically injured patients. Crit Care Med 25(11), 1789-1795.
3. D Pittet, S Rangel-Frausto, N Li, et al. (1995) Systemic inflammatory response syndrome, sepsis, severe sepsis and septic shock: incidence, morbidities and outcomes in surgical ICU patients. Intensive Care Med 21(4), 302-309.
4. MM Levy, MP Fink, JC Marshall, et al. (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31(4), 1250-1256.
5. MM Levy, MP Fink, JC Marshall, et al. (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 29(4), 530-538.
6. B Goldstein, B Giroir and A Randolph (2005) International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 6(1), 2-8.
7. M Talmor, L Hydo and PS Barie (1999) Relationship of systemic inflammatory response syndrome to organ dysfunction, length of stay, and mortality in critical surgical illness: effect of intensive care unit resuscitation. Arch Surg 134(1), 81-87.
8. K Asayama and N Aikawa (1998) Evaluation of systemic inflammatory response syndrome criteria as a predictor of mortality in emergency patients transported by ambulance. Keio J Med 47(1), 19-27.
9. MS Rangel-Frausto, D Pittet, M Costigan, et al. (1995) The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study [see comments]. JAMA 273 117-123.
10. Y Haga, T Beppu, K Doi, et al. (1997) Systemic inflammatory response syndrome and organ dysfunction following gastrointestinal surgery. Crit Care Med 25(12), 1994-2000.
11. RL Sheridan, CM Ryan, LM Yin, et al. (1998) Death in the burn unit: sterile multiple organ failure. Burns 24(4), 307-311.
12. CM Ryan, DA Schoenfeld, WP Thorpe, et al. (1998) Objective estimates of the probability of death from burn injuries. N Engl J Med 338(6), 362-366.
13. S Gando, S Nanzaki and O Kemmotsu (1999) Disseminated intravascular coagulation and sustained systemic inflammatory response syndrome predict organ dysfunctions after trauma: application of clinical decision analysis. Ann Surg 229(1), 121-127.
14. JM Still, EJ Law, K Belcher, et al. (1999) A regional medical center's experience with burns of the elderly. J Burn Care Rehabil 20(3), 218-223.
15. SE Wolf, JK Rose, MH Desai, et al. (1997) Mortality determinants in massive pediatric burns. An analysis of 103 children with > or = 80% TBSA burns (> or = 70% full-thickness). Ann Surg 225 554-565.
16. JL Kelly, C O'Sullivan, M O'Riordain, et al. (1997) Is circulating endotoxin the trigger for the systemic inflammatory response syndrome seen after injury? Ann Surg 225(5), 530-541. discussion 41–43.
17. FL Yeh, HD Shen and RH Fang (2002) Deficient transforming growth factor beta and interleukin-10 responses contribute to the septic death of burned patients. Burns 28(7), 631-637.
18. MG Schwacha and IH Chaudry (2002) The cellular basis of post-burn immunosuppression: macrophages and mediators. Int J Mol Med 10(3), 239-243.
19. HM Paterson, TJ Murphy, EJ Purcell, et al. (2003) Injury primes the innate immune system for enhanced Toll-like receptor reactivity. J Immunol 171(3), 1473-1483.
20. Y Zang, SM Dolan, NN Choileain, et al. (2004) Burn injury initiates a shift in superantigen-induced T cell responses and host survival. J Immunol 172(8), 4883-4892.
21. BO Anderson and AH Harken (1990) Multiple organ failure: inflammatory priming and activation sequences promote autologous tissue injury. J Trauma 30 S44-S49.
22. DJ Dehring, HJ Lübbesmeyer, RC Fader, et al. (1993) Exaggerated cardiopulmonary response after bacteremia in sheep with week-old thermal injury. Crit Care Med 21 888-893.
23. K Koike, FA Moore, EE Moore, et al. (1992) Endotoxin after gut ischemia/reperfusion causes irreversible lung injury. J Surg Res 52 656-662.
24. MJ Ciancio, J Hunt, SB Jones, et al. (1991) Comparative and interactive in vivo effects of tumor necrosis factor alpha and endotoxin. Circ Shock 33 108-120.
25. CE Spooner, NP Markowitz and LD Saravolatz (1992) The role of tumor necrosis factor in sepsis. Clin Immunol Immunopathol 62 S11-S17.
26. G Torre-Amione, B Bozkurt, A Deswal, et al. (1999) An overview of tumor necrosis factor alpha and the failing human heart. Curr Opin Cardiol 14(3), 206-210.
27. M Voss and MF Cotton (1998) Mechanisms and clinical implications of apoptosis. Hosp Med 59(12), 924-930.
28. T van der Poll and SJ van Deventer (1999) Cytokines and anticytokines in the pathogenesis of sepsis. Infect Dis Clin North Am 13(2), 413-426. ix.
29. GM Doherty, JR Lange, HN Langstein, et al. (1992) Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha. J Immunol 149(5), 1666-1670.
30. M Laffon, JF Pittet, K Modelska, et al. (1999) Interleukin-8 mediates injury from smoke inhalation to both the lung endothelial and the alveolar epithelial barriers in rabbits. Am J Respir Crit Care Med 160 1443-1449.
31. B Stoiser, S Knapp, F Thalhammer, et al. (1998) Time course of immunological markers in patients with the systemic inflammatory response syndrome: evaluation of sCD14, sVCAM-1, sELAM-1, MIP-1 alpha and TGF-beta 2. Eur J Clin Invest 28(8), 672-678.
32. JW Christman, LH Lancaster and TS Blackwell (1998) Nuclear factor kappa B: a pivotal role in the systemic inflammatory response syndrome and new target for therapy. Intensive Care Med 24(11), 1131-1138.
33. H Bohrer, F Qiu, T Zimmermann, et al. (1997) Role of NFkappaB in the mortality of sepsis. J Clin Invest 100(5), 972-985.
34. MD Schwartz, EE Moore, FA Moore, et al. (1996) Nuclear factor-kappa B is activated in alveolar macrophages from patients with acute respiratory distress syndrome. Crit Care Med 24(8), 1285-1292.
35. RM Graham, CJ Stephens, W Silvester, et al. (1994) Plasma degradation of platelet-activating factor in severely ill patients with clinical sepsis. Crit Care Med 22(2), 204-212.
36. D Quinn, A Tager, PM Joseph, et al. (1999) Stretch-induced mitogen-activated protein kinase activation and interleukin-8 production in type II alveolar cells. Chest 116(1 Suppl), 89S-90S.
37. A Heller, T Koch, J Schmeck, et al. (1998) Lipid mediators in inflammatory disorders. Drugs 55(4), 487-496.
38. BJ Czermak, V Sarma, CL Pierson, et al. (1999) Protective effects of C5a blockade in sepsis. Nat Med 5(7), 788-792.
39. D Annane, J Briegel and CL Sprung (2003) Corticosteroid insufficiency in acutely ill patients. N Engl J Med 348(21), 2157-2159.
40. JG Cannon, JS Friedberg, JA Gelfand, et al. (1992) Circulating interleukin-1 beta and tumor necrosis factor-alpha concentrations after burn injury in humans. Crit Care Med 20(10), 1414-1419.
41. AC Drost, DG Burleson, WG Cioffi, et al. (1993) Plasma cytokines following thermal injury and their relationship with patient mortality, burn size, and time postburn. J Trauma 35 335-339.
42. B Zhang, YH Huang, Y Chen, et al. (1998) Plasma tumor necrosis factor-alpha, its soluble receptors and interleukin-1beta levels in critically burned patients. Burns 24(7), 599-603.
43. MA Marano, Y Fong, LL Moldawer, et al. (1990) Serum cachectin/tumor necrosis factor in critically ill patients with burns correlates with infection and mortality. Surg Gynecol Obstet 170 32-38.
44. W Hubl, G Wolfbauer, J Streicher, et al. (1999) Differential expression of tumor necrosis factor receptor subtypes on leukocytes in systemic inflammatory response syndrome. Crit Care Med 27(2), 319-324.
45. E Presterl, T Staudinger, M Pettermann, et al. (1997) Cytokine profile and correlation to the APACHE III and MPM II scores in patients with sepsis. Am J Respir Crit Care Med 156(3 Pt 1), 825-832.
46. T Mandrup-Poulsen, LD Wogensen, M Jensen, et al. (1995) Circulating interleukin-1 receptor antagonist concentrations are increased in adult patients with thermal injury. Crit Care Med 23(1), 26-33.
47. AN Neely, DL Hoover, IA Holder, et al. (1996) Circulating levels of tumour necrosis factor, interleukin 6 and proteolytic activity in a murine model of burn and infection. Burns 22(7), 524-530.
48. S Aosasa, S Ono, H Mochizuki, et al. (2000) Activation of monocytes and endothelial cells depends on the severity of surgical stress. World J Surg 24(1), 10-16.
49. T Taniguchi, Y Koido, J Aiboshi, et al. (1999) Change in the ratio of interleukin-6 to interleukin-10 predicts a poor outcome in patients with systemic inflammatory response syndrome. Crit Care Med 27(7), 1262-1264.
50. S Braithwaite (2000) Procalcitonin: new insights on regulation and origin. Crit Care Med 28(2), 586-588.
51. PR Miller, DD Munn, JW Meredith, et al. (1999) Systemic inflammatory response syndrome in the trauma intensive care unit: who is infected? J Trauma 47(6), 1004-1008.
52. B Clyne and JS Olshaker (1999) The C-reactive protein. J Emerg Med 17(6), 1019-1025.
53. E Abraham, A Anzueto, G Gutierrez, et al. (1998) Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group. Lancet 351(9107), 929-933.
54. MA Clark, LD Plank, AB Connolly, et al. (1998) Effect of a chimeric antibody to tumor necrosis factor-alpha on cytokine and physiologic responses in patients with severe sepsis – a randomized, clinical trial. Crit Care Med 26(10), 1650-1659.
55. E Abraham (1997) Therapies for sepsis. Emerging therapies for sepsis and septic shock. West J Med 166(3), 195-200.
56. CJ Fisher Jr, JM Agosti, SM Opal, et al. (1996) Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N Engl J Med 334(26), 1697-1702.
57. CJ Fisher Jr, JF Dhainaut, SM Opal, et al. (1994) Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. JAMA 271(23), 1836-1843.
58. SM Opal, CJ Fisher, JFA Dhainaut, et al. (1997) Confirmatory interleukin-1 receptor antagonist trial in severe sepsis – a phase III, randomized, double-blind, placebo-controlled, multicenter trial. Crit Care Med 25 1115-1124.
59. AM Fein, GR Bernard, GJ Criner, et al. (1997) Treatment of severe systemic inflammatory response syndrome and sepsis with a novel bradykinin antagonist, deltibant (CP-0127). Results of a randomized, double-blind, placebo-controlled trial. CP-0127 SIRS and Sepsis Study Group. JAMA 277(6), 482-487.
60. JF Dhainaut, A Tenaillon, M Hemmer, et al. (1998) Confirmatory platelet-activating factor receptor antagonist trial in patients with severe gram-negative bacterial sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. BN 52021 Sepsis Investigator Group. Crit Care Med 26(12), 1963-1971.
61. JF Dhainaut, A Tenaillon, Y Le Tulzo, et al. (1994) Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: a randomized, double-blind, placebo-controlled, multicenter clinical trial. BN 52021 Sepsis Study Group. Crit Care Med 22(11), 1720-1728.
62. GR Bernard, AP Wheeler, JA Russell, et al. (1997) The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group. N Engl J Med 336(13), 912-918.
63. MT Haupt, MS Jastremski, TP Clemmer, et al. (1991) Effect of ibuprofen in patients with severe sepsis: a randomized, double-blind, multicenter study. The Ibuprofen Study Group. Crit Care Med 19 1339-1347.
64. A Sander, W Armbruster, B Sander, et al. (1997) Hemofiltration increases IL-6 clearance in early systemic inflammatory response syndrome but does not alter IL-6 and TNF alpha plasma concentrations. Intensive Care Med 23(8), 878-884.
65. JA Kellum, JP Johnson, D Kramer, et al. (1998) Diffusive vs. convective therapy: effects on mediators of inflammation in patient with severe systemic inflammatory response syndrome. Crit Care Med 26(12), 1995-2000.
66. L Cronin, DJ Cook, J Carlet, et al. (1995) Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. Crit Care Med 23(8), 1430-1439.
67. F Zeni, B Freeman and C Natanson (1997) Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment. Crit Care Med 25(7), 1095-1100.
68. RP Dellinger, JM Carlet, H Masur, et al. (2004) Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32(3), 858-873.
69. H Wang, O Bloom, M Zhang, et al. (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science 285(5425), 248-251.
70. SE Wolf, JK Rose, MH Desai, et al. (1997) Mortality determinants in massive pediatric burns. An analysis > or = 80% TBSA burns (> or = 70% full-thickness). Ann Surg 225 554-565.
71. WG Junger, R Coimbra, FC Liu, et al. (1997) Hypertonic saline resuscitation: a tool to modulate immune function in trauma patients? Shock 8(4), 235-241.
72. RJ Beale, DJ Bryg and DJ Bihari (1999) Immunonutrition in the critically ill: a systematic review of clinical outcome. Crit Care Med 27(12), 2799-2805.
73. LM Napolitano, E Faist, MW Wichmann, et al. (1999) Immune dysfunction in trauma. Surg Clin North Am 79(6), 1385-1416.
74. CN Metz and KJ Tracey (2005) It takes nerve to dampen inflammation. Nat Immunol 6(8), 756-757.
75. VA Pavlov and KJ Tracey (2005) The cholinergic anti-inflammatory pathway. Brain Behav Immun 19(6), 493-499.
76. T Brunnee, C La Porta, SR Reddigari, et al. (1993) Activation of factor XI in plasma is dependent on factor XII. Blood 81(3), 580-586.
77. R Pawlinski, B Pedersen, B Kehrle, et al. (2003) Regulation of tissue factor and inflammatory mediators by Egr-1 in a mouse endotoxemia model. Blood 101(10), 3940-3947.
78. A Messori, F Vacca, M Vaiani, et al. (2002) Antithrombin III in patients admitted to intensive care units: a multicenter observational study. Crit Care 6(5), 447-451.
79. K Okajima (2001) Regulation of inflammatory responses by natural anticoagulants. Immunol Rev 184 258-274.
80. CT Esmon (2003) The protein C pathway. Chest 124(3 Suppl), 26S-32S.
81. M Yuksel, K Okajima, M Uchiba, et al. (2002) Activated protein C inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production by inhibiting activation of both nuclear factor-kappa B and activator protein-1 in human monocytes. Thromb Haemost 88(2), 267-273.
82. GJ Broze Jr (2003) The rediscovery and isolation of TFPI. J Thromb Haemost 1(8), 1671-1675.
83. L Clemenza, F Dieli, M Cicardi, et al. (2003) Research on complement: old issues revisited and a novel sphere of influence. Trends Immunol 24(6), 292-296.
84. AF Suffredini, RE Fromm, MM Parker, et al. (1989) The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 321 280-287.
85. AF Suffredini, JH Shelhamer, RD Neumann, et al. (1992) Pulmonary and oxygen transport effects of intravenously administered endotoxin in normal humans. Am Rev Respir Dis 145 1398-1403.
86. DL Traber, H Redl, G Schlag, et al. (1988) Cardiopulmonary responses to continuous administration of endotoxin. Am J Physiol 254 H833-H839.
87. D Dehring, W Lingnau, R McGuire, et al. (1993) L-NAME transiently reverses hyperdynamic status during continuous infusion of Pseudomonas aeroginosa. Circ Shock 39 49.
88. DL Traber (1993) Models of endotoxemia in sheep. G Schlag, H Redl, DL Traber (Eds) Pathophysiology of shock sepsis and organ failure New York: Springer Verlag 194-199.
89. A Godsoe, R Kimura, D Herndon, et al. (1988) Cardiopulmonary changes with intermittent endotoxin administration in sheep. Circ Shock 25 61-74.
90. J Meyer, LD Traber, S Nelson, et al. (1992) Reversal of hyperdynamic response to continuous endotoxin administration by inhibition of NO synthesis. J Appl Physiol 73 324-328.
91. K Fujioka, K Sugi, T Isago, et al. (1991) Thromboxane synthase inhibition and cardiopulmonary function during endotoxemia in sheep. J Appl Physiol 71 1376-1381.
92. T Adams Jr and DL Traber (1982) The effects of a prostaglandin synthetase inhibitor, ibuprofen, on the cardiopulmonary response to endotoxin in sheep. Circ Shock 9 481-489.
93. R Tokyay, HM Loick, DL Traber, et al. (1992) Effects of thromboxane synthetase inhibition on postburn mesenteric vascular resistance and the rate of bacterial translocation in a chronic porcine model. Surg Gynecol Obstet 174 125-132.
94. G Redl, S Abdi, RJ Nichols, et al. (1991) The effects of a selective thromboxane synthetase inhibitor on the response of the right heart to endotoxin in sheep. Crit Care Med 19 1294-1302.
95. RL Navaratnam, SE Morris, DL Traber, et al. (1990) Endotoxin (LPS) increases mesenteric vascular resistance (MVR) and bacterial translocation (BT). J Trauma 30 1104-1113.
96. AM Lefer (1987) Interaction between myocardial depressant factor and vasoactive mediators with ischemia and shock. Am J Physiol 252 R193-R205.
97. SE Morris, N Navaratnam and DN Herndon (1990) A comparison of effects of thermal injury and smoke inhalation on bacterial translocation. J Trauma 30 639-643.
98. G Schlag, H Redl, J Davies, et al. (1991) Aspects of the mechanisms of bacterial translocation in a hypovolemic-traumatic shock mode in baboons. Circ Shock 34 26-27.
99. D Xu, L Qi, D Guillory, et al. (1993) Mechanisms of endotoxin-induced intestinal injury in a hyperdynamic model of sepsis. J Trauma 34 676-682.
100. M Koltai, D Hosford and PG Braquet (1993) Platelet-activating factor in septic shock. New Horizons 1 87-95.
101. DL Traber (1987) Endotoxin: the causative factor of mediator release during sepsis. G Schlag, H Redl (Eds) Progress in clinical and biological research New York: Alan R. Liss 377-392.
102. GD Martich, RL Danner, M Ceska, et al. (1991) Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents. J Exp Med 173 1021-1024.
103. HR Michie, KR Manogue, DR Spriggs, et al. (1988) Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 318 1481-1486.
104. DR Morel, JF Pittet, K Gunning, et al. (1991) Time course of plasma and pulmonary lymph endothelin-like immunoreactivity during sustained endotoxaemia in chronically instrumented sheep. Clin Sci 81 357-365.
105. G Redl, L Woodson, LD Traber, et al. (1992) Mechanism of immunoreactive atrial natriuretic factor release in an ovine model of endotoxemia. Circ Shock 38 34-41.
106. HJ Lübbesmeyer, L Woodson, LD Traber, et al. (1988) Immunoreactive atrial natriuretic factor is increased in ovine model of endotoxemia. Am J Physiol 254 R567. RR71
107. JF Pittet, DR Morel, A Hemsen, et al. (1991) Elevated plasma endothelin-1 concentrations are associated with the severity of illness in patients with sepsis. Ann Surg 213 261-264.
108. PJ Sloane, TH Elsasser, JA Spath, et al. (1992) Plasma tumor necrosis factor-alpha during long-term endotoxemia in awake sheep. J Appl Physiol 73 1831-1837.
109. DR Morel, JS Lacroix, A Hemsen, et al. (1989) Increased plasma and pulmonary lymph levels of endothelin during endotoxin shock. Eur J Pharmacol 167 427-428.
110. S Nelson, RH Steward, L Traber, et al. (1991) Endotoxin-induced alterations in contractility of isolated blood vessels from sheep. Am J Physiol 260 H1790-H1794.
111. JL Theissen, HM Loick, BB Curry, et al. (1991) Time course of hypoxic pulmonary vasoconstriction after endotoxin infusion in unanesthetized sheep. J Appl Physiol 70 2120-2125.
112. J Meyer, CW Lentz, JC Stothert, et al. (1994) Effects of nitric oxide synthesis inhibition in hyperdynamic endotoxemia. Crit Care Med 22 306-312.
113. K Sugi, J Newald, LD Traber, et al. (1991) Cardiac dysfunction after acute endotoxin administration in conscious sheep. Am J Physiol 260 H1474-H1481.
114. S Noshima, H Noda, DN Herndon, et al. (1993) Left ventricular performance during continuous endotoxin-induced hyperdynamic endotoxemia in sheep. J Appl Physiol 74 1528-1533.
115. PR Myers, TF Wright, MA Tanner, et al. (1992) EDRF and nitric oxide production in cultured endothelial cells: direct inhibition by E. coli endotoxin. Am J Physiol 262 H710-H718.
116. P Vallance and S Moncada (1993) Role of endogenous nitric oxide in septic shock. New Horizons 1 77-86.
117. N Sakai and S Milstien (1993) Availability of tetrahydrobiopterin is not a factor in the inability to detect nitric oxide production by human macrophages. Biochem Biophys Res Com 193 378-383.
118. M Schneemann, G Schoedon, S Hofer, et al. (1993) Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. J Infect Dis 167 1358-1363.
119. S Moncada (1997) Nitric oxide in the vasculature: physiology and pathophysiology. Ann NY Acad Sci 811 60-67.
120. RF Furchgott (1999) Endothelium-derived relaxing factor: discovery, early studies, and identification as nitric oxide. Biosci Rep 19 235-251.
121. A Petros, G Lamb, A Leone, et al. (1994) Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res 28 34-39.
122. S Geroulanos, J Schilling, M Cakmakci, et al. (1992) Inhibition of NO synthesis in septic shock. Lancet 339 435-440.
123. MG Kiehl, H Ostermann, J Meyer, et al. (1997) Nitric oxide synthase inhibition by L-NAME in leukocytopenic patients with severe septic shock. Intensive Care Med 23(5), 561-566.
124. Y Shi, HQ Li, CK Shen, et al. (1993) Plasma nitric oxide levels in newborn infants with sepsis. J Pediatr 123 435-438.
125. JB Ochoa, AO Udekwu, TR Billiar, et al. (1991) Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 214 621-626.
126. F Schneider, P Lutun, A Couchot, et al. (1993) Plasma cyclic guanosine 3′-5′ monophosphate concentrations and low vascular resistance in human septic shock. Intensive Care Med 19 99-104.
127. F Schuller, I Fleming, JC Stoclet, et al. (1992) Effect of endotoxin on circulating cyclic GMP in the rat. Eur J Pharmacol 212 93-96.
128. SH Nelson, DJ Dehring, JS Ehardt, et al. (1993) Regional variation in content of c-GMP and associated vascular reactivity in bacteremia. Circ Shock 39 54.
129. W Martin, DG White and AH Henderson (1988) Endothelium-derived relaxing factor and atriopeptin II elevate cyclic GMP levels in pig aortic endothelial cells. Br J Pharmacol 93 229-239.
130. JA Cherner, G Singh and L Naik (1990) Atrial natriuretic factor activates membrane-bound guanylate cyclase of chief cells. Life Sci 47 669-677.
131. MF Goy (1990) Activation of membrane guanylate cyclase by an invertebrate peptide hormone. J Biol Chem 265 20220-20227.
132. C Boulanger, VB Schini, S Moncada, et al. (1990) Stimulation of cyclic GMP production in cultured endothelial cells of the pig by bradykinin, adenosine diphosphate, calcium ionophore A23187 and nitric oxide. Br J Pharmacol 101 152-156.
133. DC Leitman, VL Agnost, RM Catalano, et al. (1988) Atrial natriuretic peptide, oxytocin, and vasopressin increase guanosine 3′,5′-monophosphate in LLC-PK1 kidney epithelial cells. Endocrinology 122 1478-1485.
134. DL Garbers (1990) The guanylyl cyclase receptor family. New Biologist 2 499-504.
135. JR Snapper, KL Brigham, AC Heflin, et al. (1983) Effects of endotoxemia on cyclic nucleotides in the unanesthetized sheep. J Lab Clin Med 102 240-249.
136. RA DeLa Cadena, AF Suffredini, JD Page, et al. (1993) Activation of the kallikrein-kinin system after endotoxin administration to normal human volunteers. Blood 81 3313-3317.
137. R Mann, LC Woodson, LD Traber, et al. (1991) Role of bradykinin in ovine endotoxemia. Circ Shock 34 224-230.
138. T Matsuda, CA Eccleston, I Rubinstein, et al. (1991) Antioxidants attenuate endotoxin-induced microvascular leakage of macromolecules in vivo. Am J Physiol 70 1483-1489.
139. H Nakazawa, H Noda, S Noshima, et al. (1993) Pulmonary transvascular fluid flux and cardiovascular function in sheep with chronic sepsis. J Appl Physiol 75 2521-2528.
140. EM Landis and JR Pappenheimer (1963) Exchange of substances through the capillary walls. WF Hamilton, P Dow (Eds) Handbook of physiology 2 Baltimore, MD: Williams & Wilkins 961-1034. (2)
141. EH Starling (1896) On the absorption of fluids from the connective tissue spaces. J Physiol 19 312-326.
142. KL Brigham, R Bowers and J Haynes (1979) Increased sheep lung vascular permeability caused by Escherichia coli endotoxin. Circ Res 45 292-297.
143. KA Gaar, AE Taylor, LJ Owens, et al. (1967) Effect of capillary pressure and plasma protein on development of pulmonary edema. Am J Physiol 213 79-82.
144. T Lund, H Wiig, RK Reed, et al. (1987) A ‘new’ mechanism for oedema generation: strongly negative interstitial fluid pressure causes rapid fluid flow into thermally injured skin. Acta Physiol Scand 129 433-435.
145. T Lund, H Wiig and RK Reed (1988) Acute postburn edema: role of strongly negative interstitial fluid pressure. Am J Physiol 255 H1069-H1074.
146. DL Traber, DN Herndon, K Fujioka, et al. (1991) Permeability changes during experimental endotoxemia and sepsis. G Schlag, H Redl, JH Siegel, et al., (Eds) Shock, sepsis, and organ failure: Second Wiggers Bernard conference New York: Springer-Verlag 425-447.
147. L Smith, S Andreasson, K Thoren Tolling, et al. (1987) Sepsis in sheep reduces pulmonary microvascular sieving capacity. J Appl Physiol 62 1422-1429.
148. JA Oliver (1992) Endothelium-derived relaxing factor contributes to the regulation of endothelial permeability. J Cell Physiol 151 506-511.
149. IS Farrukh, GH Gurtner and JR Michael (1987) Pharmacological modification of pulmonary vascular injury: possible role of cAMP. J Appl Physiol 62 47-54.
150. I Kurose, P Kubes, R Wolf, et al. (1993) Inhibition of nitric oxide production. Mechanisms of vascular albumin leakage. Circ Res 73 164-171.
151. FM Leeuwenberg, TMA Jeunhomme and WA Buurman (1989) Induction of an activation antigen on human endothelial cells in vitro. Eur J Immunol 19 715-720.
152. LA Lasky (1992) Selectins: interpreters of cell-specific carbohydrate information during inflammation. Science 258 964-969.
153. PP Nawroth and DM Stern (1986) Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 163 740-745.
154. CJ Walsh, D Carey, DJ Cook, et al. (1991) Anti-CD18 antibody attenuates neutropenia and alveolar capillary-membrane injury during gram-negative sepsis. Surgery 110 205-212.
155. CM Doerschuk, RK Winn, HO Coxson, et al. (1990) CD18-dependent and -independent mechanisms of neutrophil emigration in the pulmonary and systemic microcirculation of rabbits. J Immunol 144 2327-2333.
156. CZ Wang, RE Barrow, CS Cox, et al. (1993) Influence of detergent aerosol on lung microvascular permeability. J Appl Physiol 74 1016-1023.
157. DL Traber (1987) Anti-proteases in endotoxemia. Prog Clin Biol Res 236 149-157.
158. A Seekamp, C LaLonde, DG Zhu, et al. (1988) Catalase prevents prostanoid release and lung lipid peroxidation after endotoxemia in sheep. J Appl Physiol 65 1210-1216.
159. JO Basadre, H Singh, DN Herndon, et al. (1988) Effect of antibody-mediated neutropenia on the cardiopulmonary response to endotoxemia. J Surg Res 45 266-275.
160. R Winn, R Maunder, E Chi, et al. (1987) Neutrophil depletion does not prevent lung edema after endotoxin infusion in goats. J Appl Physiol 62 116-121.
161. RJ Maunder, RC Hackman, E Riff, et al. (1986) Occurrence of the adult respiratory distress syndrome in neutropenic patients. Am Rev Respir Dis 133 313-316.
162. MD Laufe, RH Simon, A Flint, et al. (1986) Adult respiratory distress syndrome in neutropenic patients. Am J Med 80 1022-1026.
163. AC Heflin Jr and KL Brigham (1981) Prevention by granulocyte depletion of increased vascular permeability of sheep lung following endotoxemia. J Clin Invest 68 1253-1260.
164. JM Klausner, IS Paterson, G Goldman, et al. (1991) Interleukin-2-induced lung injury is mediated by oxygen free radicals. Surgery 109 169-175.
165. G Goldman, R Welbourn, JM Klausner, et al. (1991) Thromboxane mediates diapedesis after ischemia by activation of neutrophil adhesion receptors interacting with basally expressed intercellular adhesion molecule-1. Circ Res 68 1013-1019.
166. DL Traber, G Schlag, H Redl, et al. (1987) Pulmonary microvascular changes during hyperdynamic sepsis in an ovine model. Circ Shock 22 185-193.
167. FN Miller and DE Sims (1986) Contractile elements in the regulation of macromolecular permeability. Fed Proc 45 84-88.
168. IS Paterson, JM Klausner, G Goldman, et al. (1989) Thromboxane mediates the ischemia-induced neutrophil oxidative burst. Surgery 106 224-229.
169. RK Turker, HE Aksulu, ZS Ercan, et al. (1987) Thromboxane A2 inhibitors and iloprost prevent angiotensin II-induced oedema in the isolated perfused rat lung. Arch Int Pharmacodyn Ther 287 323-329.
170. EA Deitch, M Taylor, M Grisham, et al. (1989) Endotoxin induces bacterial translocation, and increases xanthine oxidase activity. J Trauma 29 1679-1683.
171. EA Deitch, L Ma, WJ Ma, et al. (1989) Inhibition of endotoxin-induced bacterial translocation, in mice. J Clin Invest 84 36-42.
172. LS Terada, JJ Dormish, PF Shanley, et al. (1992) Circulating xanthine oxidase mediates lung neutrophil sequestration after intestinal ischemia-reperfusion. Am J Physiol 263 L394-L401.
173. H Redl, G Schlag and H Lamche (1990) TNF- and LPS-induced changes of lung vascular permeability: studies in unanesthetised sheep. Circ Shock 31 183-192.
174. J Johnson, B Meyrick, G Jesmok, et al. (1989) Human recombinant tumor necrosis factor alpha infusion mimics endotoxemia in awake sheep. J Appl Physiol 66 1448-1454.
175. KE Burhop, JG Garcia, WM Selig, et al. (1986) Platelet-activating factor increases lung vascular permeability to protein. J Appl Physiol 61 2210-2217.
176. CN Sessler, FL Glauser, D Davis, et al. (1988) Effects of platelet-activating factor antagonist SRI 63–441 on endotoxemia in sheep. J Appl Physiol 65 2624-2631.
177. GM Vercellotti, HQ Yin, KS Gustavson, et al. (1988) Platelet activating factor primes neutrophil responses to agonists: role in promoting neutrophil-mediated endothelial damage. Blood 71 1100-1107.
178. H Holloway, M Perry, J Downey, et al. (1983) Estimation of effective pulmonary capillary pressure in intact lungs. J Appl Physiol 54(3), 846-851.
179. ST O'Dwyer, HR Michie, TR Ziegler, et al. (1988) A single dose of endotoxin increases intestinal permeability in healthy humans. Arch Surg 123 1459-1464.
180. RM Roumen, T Hendriks, RA Wevers, et al. (1993) Intestinal permeability after severe trauma and hemorrhagic shock is increased without relation to septic complications. Arch Surg 128 453-457.
181. ST Zeigler, DL Traber and DN Herndon (1993) Bacterial translocation in burns. G Schlag, H Redl (Eds) Pathophysiology of shock, sepsis, and organ failure New York: Springer-Verlag 300-313.